Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,043

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Systemic Therapy for Colorectal Cancer

Meyerhardt, Jeffrey A., Mayer, Robert J.·2005·New England Journal of Medicine

Abstract

Colorectal cancer is one of the most commonly diagnosed malignant diseases, with an estimated 1,023,000 new cases and 529,000 deaths worldwide each year. This review considers recently developed cytotoxic chemotherapies and biologic agents that are effective against colorectal cancer and assesses their use as treatments for metastatic disease and as components of adjuvant therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmra040958

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 96

  1. 10.3322/canjclin.55.1.10 · DOI · Paper page
  2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0. Lyon, France: IARC Press, 2004.
  3. 10.1056/NEJM199404213301608 · DOI · Paper page
  4. 10.1016/S0140-6736(00)02034-1 · DOI · Paper page
  5. 10.1016/S0305-7372(02)00037-3 · DOI
  6. 10.1002/path.1700350303 · DOI · Paper page
  7. Greene FL, Balch CM, Fleming ID, et al., eds. AJCC cancer staging handbook. 6th ed. New York: Springer, 2002. · DOI · Paper page
  8. 10.1136/bmj.306.6880.752 · DOI · Paper page
  9. Smyth JF, 1995, Ann Oncol, 6, 948, 10.1093/oxfordjournals.annonc.a059365 · DOI
  10. 10.1016/S0140-6736(94)90750-1 · DOI · Paper page
  11. 2000, Cochrane Database Syst Rev, 2, CD001545
  12. Sobrero A, 2000, Semin Oncol, 27, 72
  13. Zhang ZG, 1992, Semin Oncol, 19, 10
  14. 10.1200/JCO.2004.03.104 · DOI · Paper page
  15. Lokich JJ, 1989, J Clin Oncol, 7, 425, 10.1200/JCO.1989.7.4.425 · DOI · Paper page
  16. de Gramont A, 1997, J Clin Oncol, 15, 808, 10.1200/JCO.1997.15.2.808 · DOI · Paper page
  17. Weh HJ, 1994, Ann Oncol, 5, 233, 10.1093/oxfordjournals.annonc.a058799 · DOI
  18. 10.1002/(SICI)1097-0142(19960715)78:2<300::AID-CNCR17>3.0.CO;2-# · doi:10.1002/(sici)1097-0142(19960715)78:2<300::aid-cncr17>3.0.co;2-#
  19. 10.1002/(SICI)1097-0142(19960715)78:2<294::AID-CNCR16>3.0.CO;2-R · doi:10.1002/(sici)1097-0142(19960715)78:2<294::aid-cncr16>3.0.co;2-r
  20. 10.1200/JCO.2003.11.122 · DOI · Paper page
  21. 1998, J Clin Oncol, 16, 301, 10.1200/JCO.1998.16.1.301 · DOI · Paper page
  22. 10.1002/1097-0142(197504)35:4<1031::AID-CNCR2820350403>3.0.CO;2-N · doi:10.1002/1097-0142(197504)35:4<1031::aid-cncr2820350403>3.0.co;2-n
  23. Pentheroudakis G, 2002, Anticancer Res, 22, 3589
  24. 10.1016/S0959-8049(98)00226-3 · DOI
  25. Sulkes A, 1998, J Clin Oncol, 16, 3461, 10.1200/JCO.1998.16.10.3461 · doi:10.1200/jco.1998.16.10.3461
  26. 10.1016/S0959-8049(98)00211-1 · DOI · Paper page
  27. Van Cutsem E, 2001, J Clin Oncol, 19, 4097, 10.1200/JCO.2001.19.21.4097 · DOI · Paper page
  28. Hoff PM, 2001, J Clin Oncol, 19, 2282, 10.1200/JCO.2001.19.8.2282 · DOI · Paper page
  29. Mayer RJ, 2001, J Clin Oncol, 19, 4093, 10.1200/JCO.2001.19.21.4093 · DOI
  30. 10.1200/JCO.2002.10.129 · DOI · Paper page
  31. 10.1200/JCO.2002.04.123 · DOI · Paper page
  32. Ward S, 2003, Health Technol Assess, 7, 1, 10.3310/hta7320 · DOI · Paper page
  33. 10.1001/jama.259.24.3571 · doi:10.1001/jama.259.24.3571 · Paper page
  34. Moertel CG, 1995, Ann Intern Med, 122, 321, 10.7326/0003-4819-122-5-199503010-00001 · DOI · Paper page
  35. Haller DG, 1993, Adv Exp Med Biol, 339, 51, 10.1007/978-1-4615-2488-5_6 · doi:10.1007/978-1-4615-2488-5_6
  36. Haller DG, 1998, Proc Am Soc Clin Oncol, 17, 982
  37. Wolmark N, 1999, J Clin Oncol, 17, 3553, 10.1200/JCO.1999.17.11.3553 · DOI · Paper page
  38. 10.1200/JCO.2004.09.059 · DOI · Paper page
  39. Wolmark N, 2004, J Clin Oncol, 22, 3508, 10.1200/jco.2004.22.14_suppl.3508 · DOI
  40. 10.1056/NEJMoa010957 · DOI · Paper page
  41. Mamounas E, 1999, J Clin Oncol, 17, 1349, 10.1200/JCO.1999.17.5.1349 · DOI · Paper page
  42. Moertel CG, 1995, J Clin Oncol, 13, 2936, 10.1200/JCO.1995.13.12.2936 · DOI · Paper page
  43. 1999, J Clin Oncol, 17, 1356, 10.1200/JCO.1999.17.5.1356 · DOI · Paper page
  44. 10.1200/JCO.2004.05.063 · DOI · Paper page
  45. 10.1002/(SICI)1097-0142(19980901)83:5<882::AID-CNCR12>3.0.CO;2-R · doi:10.1002/(sici)1097-0142(19980901)83:5<882::aid-cncr12>3.0.co;2-r
  46. 10.1385/IJGC:30:3:147 · DOI
  47. 10.1200/JCO.20.6.1499 · DOI · Paper page
  48. 10.1097/00000658-199812000-00006 · DOI · Paper page
  49. 10.1056/NEJM199912303412702 · DOI · Paper page
  50. 10.1007/s002800051077 · doi:10.1007/s002800051077
  51. 10.1067/mcp.2002.129502 · DOI
  52. Mathijssen RH, 2001, Clin Cancer Res, 7, 2182
  53. 10.1038/sj.tpj.6500072 · DOI · Paper page
  54. 10.1023/A:1008438109725 · DOI · Paper page
  55. 10.1200/JCO.2004.07.173 · DOI · Paper page
  56. 10.1016/S0140-6736(98)03085-2 · DOI · Paper page
  57. 10.1056/NEJM200009283431302 · DOI · Paper page
  58. Rothenberg ML, 2001, J Clin Oncol, 19, 3801, 10.1200/JCO.2001.19.18.3801 · DOI · Paper page
  59. Goldberg RM, 2004, J Clin Oncol, 22, 3621, 10.1200/jco.2004.22.14_suppl.3621 · doi:10.1200/jco.2004.22.14_suppl.3621
  60. Hwang JJ, 2003, Oncology (Huntingt), 17, 37
  61. Raymond E, 1998, Semin Oncol, 25, 4
  62. 10.1016/S0006-2952(97)81490-6 · DOI · Paper page
  63. 10.1097/00001813-199710000-00009 · DOI · Paper page
  64. 10.1200/JCO.2003.11.126 · DOI · Paper page
  65. Raymond E, 2002, Mol Cancer Ther, 1, 227
  66. 10.1016/S0093-7754(03)00399-3 · DOI · Paper page
  67. de Gramont A, 2000, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938 · DOI · Paper page
  68. Becouarn Y, 1998, J Clin Oncol, 16, 2739, 10.1200/JCO.1998.16.8.2739 · DOI · Paper page
  69. 10.1023/A:1008200825886 · DOI · Paper page
  70. 10.1016/0959-8049(93)90073-O · DOI · Paper page
  71. Machover D, 1996, Ann Oncol, 7, 95, 10.1093/oxfordjournals.annonc.a010489 · DOI · Paper page
  72. Giacchetti S, 2000, J Clin Oncol, 18, 136, 10.1200/JCO.2000.18.1.136 · DOI · Paper page
  73. Grothey A, Deschler B, Kroening H, et al. Phase III study of bolus 5-fluorouracil (5-FU)/ folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU infusion/ FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC). In: Program and abstracts of the American Society of Clinical Oncology 38th Annual Meeting, Orlando, Fla., May 18–21, 2002. abstract. · DOI
  74. 10.1200/JCO.2004.09.046 · DOI · Paper page
  75. Grothey A, 2003, Prog Proc Am Soc Clin Oncol, 22, 255
  76. 10.1200/JCO.2004.11.037 · DOI · Paper page
  77. 10.1200/JCO.2004.10.182 · DOI · Paper page
  78. 10.1056/NEJMoa032709 · DOI · Paper page
  79. 10.1634/theoncologist.7-suppl_4-2 · doi:10.1634/theoncologist.7-suppl_4-2 · Paper page
  80. 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2 · DOI · Paper page
  81. 10.1002/jso.2930510304 · DOI
  82. 10.1016/S0889-8588(02)00055-2 · DOI
  83. Saltz L, 2001, Prog Proc Am Soc Clin Oncol, 20, 3a
  84. 10.1200/JCO.2004.10.182 · DOI · Paper page
  85. 10.1200/JCO.2003.10.066 · DOI · Paper page
  86. Kabbinavar F, 2004, J Clin Oncol, 22, 3516, 10.1200/jco.2004.22.14_suppl.3516 · doi:10.1200/jco.2004.22.14_suppl.3516
  87. Saltz L, 2003, Prog Proc Am Soc Clin Oncol, 22, 204a
  88. Berlin JD, 2002, Oncology (Huntingt), 16, 13
  89. 10.1007/s11912-001-0008-5 · doi:10.1007/s11912-001-0008-5
  90. Kornmann M, 2003, Clin Cancer Res, 9, 4116
  91. 10.1016/S1091-255X(02)00018-5 · doi:10.1016/s1091-255x(02)00018-5
  92. 10.1200/JCO.2003.07.039 · DOI
  93. Berglund A, 2002, Anticancer Res, 22, 3653
  94. Aschele C, 2000, Clin Cancer Res, 6, 4797
  95. 10.2165/00003088-200039050-00001 · DOI
  96. 10.1038/sj.bjc.6601487 · doi:10.1038/sj.bjc.6601487

Cited by

See all 1,043

Metadata

Authors
Meyerhardt, J. A., & Mayer, R. J.
Venue
New England Journal of Medicine
Published
2005-02-03
Volume
352
Issue
5
Pages
476-487
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2069305509
Cited by
1,043
References
8
FWCI
30.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systemic Therapy for Colorectal Cancer. https://app.cochat.ai/papers/10.1056/nejmra040958
The paper
Meyerhardt, J. A., & Mayer, R. J. (2005). Systemic Therapy for Colorectal Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmra040958

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.